Bruce Eaton - Aug 9, 2021 Form 4 Insider Report for Editas Medicine, Inc. (EDIT)

Role
EVP, CHIEF BUSINESS OFFICER
Signature
/s/ Bruce Eaton
Stock symbol
EDIT
Transactions as of
Aug 9, 2021
Transactions value $
-$41,115
Form type
4
Date filed
4/4/2022, 04:30 PM
Previous filing
Jul 30, 2021
Next filing
Nov 10, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction EDIT Common Stock Sale -$16.4K -287 -0.42% $57.17* 68.1K Aug 9, 2021 Direct F1
transaction EDIT Common Stock Sale -$24.7K -1.26K -1.85% $19.64 66.8K Apr 1, 2022 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Sale was effected pursuant to a durable automatic sales instruction plan adopted by the Reporting Person on June 15, 2019, and represents the sale of shares by the Issuer necessary to meet tax withholding obligations as a result of vesting in restricted stock units on August 6, 2021. The sale does not represent a discretionary trade by the Reporting Person.
F2 Sale was effected pursuant to a durable automatic sales instruction plan adopted by the Reporting Person on June 15, 2019, and represents the sale of shares by the Issuer necessary to meet tax withholding obligations as a result of vesting in restricted stock units on March 31, 2022. The sale does not represent a discretionary trade by the Reporting Person.